COVID-19

News

Pfizer shares slump as support grows for COVID-19 vaccine pa...

Shares in COVID-19 vaccine manufacturers have taken a hit after the US signalled its support for waiving patents on them, a move aimed to boost global supplies of the life-saving shots.

News

Nebuliser being filled. Copyright Vectura (002)

New UK biotech Inspira uncloaks with deal to develop inhaled...

UK biotech Inspira Pharmaceuticals has emerged from stealth mode with a deal with Vectura to develop an inhaled therapy for COVID-19 that could be ready for human testing within 12 months.&

Views & Analysis

Building a better future for people with rare diseases in all four UK nations

Creating a global life sciences superpower from the lessons ...

It’s time to take what the UK has learnt about the “Holy Trinity” of government, academia, and industry and apply it to creating a “life sciences superpower”, says health secretary Matt Han

News

Pfizer says COVID-19 jab could rake in $26bn this year

Pfizer expects revenues from its BioNTech-partnered COVID-19 vaccine to reach an eye-watering $26 billion this year, catapulting it to the top of the world's biggest-selling medicines.

Partner Content